Boltwood Capital Management Biogen Inc. Transaction History

Boltwood Capital Management

$336 Million
Q3 2024

A detailed history of Boltwood Capital Management transactions in Biogen Inc. stock. As of the latest transaction made, Boltwood Capital Management holds 1,197 shares of BIIB stock, worth $208,026. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,197

Previous 1,204 0.58%

Holding current value

$208,026

Previous $279,000 16.85%

% of portfolio

0.07%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$189.07 - $236.8 $1,323 - $1,657	-7 Reduced 0.58%	1,197 $232,000
Q2 2024 Jul 08, 2024	SELL	$190.52 - $236.72 $10,669 - $13,256	-56 Reduced 4.44%	1,204 $279,000
Q1 2024 Apr 04, 2024	BUY	$212.02 - $267.71 $2,756 - $3,480	13 Added 1.04%	1,260 $271,000
Q4 2023 Jan 05, 2024	SELL	$222.59 - $267.94 $2,225 - $2,679	-10 Reduced 0.8%	1,247 $322,000
Q3 2023 Oct 10, 2023	SELL	$253.3 - $285.89 $2,786 - $3,144	-11 Reduced 0.87%	1,257 $323,000
Q2 2023 Jul 06, 2023	SELL	$275.25 - $318.06 $5,505 - $6,361	-20 Reduced 1.55%	1,268 $361,000
Q1 2023 Apr 03, 2023	SELL	$256.56 - $292.34 $513 - $584	-2 Reduced 0.16%	1,288 $358,000
Q4 2022 Jan 06, 2023	SELL	$252.44 - $306.72 $6,815 - $8,281	-27 Reduced 2.05%	1,290 $0
Q3 2022 Oct 04, 2022	BUY	$194.69 - $268.46 $11,681 - $16,107	60 Added 4.77%	1,317 $352,000
Q2 2022 Jul 07, 2022	BUY	$187.54 - $223.02 $235,737 - $280,336	1,257 New	1,257 $256,000
Q2 2019 Jul 01, 2019	SELL	$219.29 - $241.72 $464,017 - $511,479	-2,116 Closed	0 $0
Q1 2019 Apr 02, 2019	BUY	$216.71 - $338.96 $27,955 - $43,725	129 Added 6.49%	2,116 $500,000
Q4 2018 Jan 07, 2019	SELL	$278.5 - $352.75 $10,861 - $13,757	-39 Reduced 1.92%	1,987 $597,000
Q3 2018 Oct 10, 2018	BUY	$293.51 - $383.83 $10,859 - $14,201	37 Added 1.86%	2,026 $715,000
Q2 2018 Jul 06, 2018	BUY	$257.52 - $306.91 $11,588 - $13,810	45 Added 2.31%	1,989 $577,000
Q1 2018 Apr 05, 2018	SELL	$260.13 - $367.91 $10,665 - $15,084	-41 Reduced 2.07%	1,944 $532,000
Q4 2017 Jan 10, 2018	SELL	$307.64 - $344.58 $192,275 - $215,362	-625 Reduced 23.95%	1,985 $632,000
Q3 2017 Oct 10, 2017	BUY	$281.15 - $329.69 $733,801 - $860,490	2,610	2,610 $817,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Boltwood Capital Management with notifications on news.

Account

Boltwood Capital Management Biogen Inc. Transaction History